The cyclin-dependent kinase inhibitor p15
INK4b has been shown to be involved in human and rodent tumors and seems to act as a tumor suppressor gene in hematological malignancies. Alterations of this gene in tumors include mainly homozygous deletions and hypermethylation of the CpG island in the promoter region. In this work, we describe a new area sensitive to methylation in the 3' untranslated region (UTR) of the murine p15
INK4b gene. This region shows dierent levels of methylation depending on the tissues, being relatively highly methylated in brain and gut, and weakly methylated in liver, spleen or thymus. DNA methylation and expression is similar in both maternal and paternal alleles indicating no imprinting eect. Although methylation of the p15
INK4b
3'-UTR is low in normal thymus, increased levels (up to 100%) of speci®c methylation in this region are found in up to 30% of radiation-or carcinogen-induced thymic lymphomas, correlating with decreased gene expression.
Hypermethylation of the p15
INK4b 3'-UTR frequently occurs in tumors with loss of heterozygosity (LOH) but without methylation of the promoter CpG island or intragenic mutations. Furthermore, in vitro CpG methylation of the 3'-UTR produces reduced levels of a luciferase reporter in cultured cells. Methylation of two CpG sites in a 120 bp region is sucient to interfere with transcription of the reporter gene. These data suggest that although the levels of p15
INK4b in normal tissues can be mainly determined by promoter regulatory elements, strong hypermethylation of the 3'-UTR can interfere with transcription. Thus, hypermethylation of
Introduction

The p15
INK4b gene (Hannon and Beach, 1994) belongs to the INK4 family of cyclin-dependent kinase inhibitors (CDKIs), involved in the regulation of the mammalian cell cycle progression (Sherr and Robert, 1995) . The members of the INK4 family (p16
INK4b , p18
INK4c and p19
INK4d
) speci®cally inhibit the complexes formed by cyclin D (D1, D2 or D3) and the cyclin-dependent kinases (CDKs) 4 or 6. These CDKIs share multiple ankyrin repeat motifs and modulate the phosphorylation of the retinoblastoma (Rb) protein by cyclin D-CDK4/6, eliciting a G1 block of the cell cycle (Sherr and Robert, 1995; GranÄ a and Reddy, 1995; Harper and Elledge, 1996) . A dierent family of CDKIs includes p21
CIP1,WAF1
, p27
KIP1 and p57
KIP2
. The members of this family inhibit all G1/S phase CDKs Sherr, 1996) . p21
CIP1 is induced directly by p53 and mediates p53-dependent cell cycle arrest and inhibition of DNA replication. p27 KIP1 tends to accumulate in quiescent cells and declines in response to growth factor stimulation (Sherr and Robert, 1995; Harper and Elledge, 1996) .
The p15
INK4b protein is an important mediator of the antiproliferative eect of TGF-b (Hannon and Beach, 1994, ReynisdoÂ ttir et al., 1995) . TGF-b regulates p15
INK4b at least at two levels: producing a mRNA accumulation through several Sp1 sites in its promoter (Hannon and Beach, 1994; Li et al., 1995) and increasing the protein stability (Shandu et al., 1997) . The antiproliferative eect of TGF-b, however, is not restricted to p15
INK4b , since TGF-b can produce cell cycle arrest in p15
INK4b
-de®cient cells through repression of the CDK tyrosine phosphatase Cdc25A (Iavarone and MassagueÂ , 1997) . Formation of p15
INK4b -CDK4 complexes at the expense of cyclin D increases the pool of free p27
KIP1
, producing a inhibition of the cyclin E-CDK2 complexes as well (Sherr and Robert, 1995; Peters, 1994) .
Dierent evidences have shown the involvement of some CDKIs in carcinogenesis. The p16
INK4a
and p15
INK4b genes, which lie very close in the human and murine chromosomes (Kamb et al., 1994; Quelle et al., 1995) , are frequently deleted in a wide range of tumors Hirama and Koeer, 1995) . Deletions most frequently involve both p16
INK4a
and p15
INK4b . Although p16 INK4a is thought as the main target for these deletions (Cairns et al., 1995) , speci®c deletion of p15
INK4b has been found in some cases (Jen et al., 1994; Glendeling et al., 1995; Rasool et al., 1995) . Inactivation of these genes occurs also by point mutations (Pollock et al., 1996) or by hypermethylation of their promoter region Herman et al., 1996) . Both p16
INK4a and p15
INK4b genes, in human and rodents, show a CpG island in their promoter region and de novo methylation of this region has been found in a signi®cant percentage of tumors, being correlated with the lack or decreased gene expression Herman et al., 1997; Malumbres et al., 1997) . Although p16
INK4a
is inactivated by hypermethylation in a wide spectrum of tumors, the hypermethylation of the p15
INK4b CpG island seems to be more restricted to hematological malignancies (Herman et al., 1996 (Herman et al., , 1997 . None of the other members of the INK4 family, p18
INK4c or p19
INK4d
, have been de®nitively involved in tumorigenesis.
Since the importance of p15
INK4b
as a tumor suppressor gene and its inactivation by promoter hypermethylation in hematological malignancies (Herman et al., 1997; Batova et al., 1997; Malumbres et al., 1997) , we have further investigated the pattern of methylation of p15
INK4b in normal and tumoral tissues. We found some thymic lymphomas in which the lack of p15
INK4b expression cannot be explained by promoter methylation. We report in this article that this subset of tumors have a high level of hypermethylation in the 3'-untranslated region (UTR) and that hypermethylation of this area produces decreased gene expression in a in vitro reporter system. Although no methylation of the p15
INK4b promoter region is found in normal tissues, the 3'-UTR is dierentially methylated in normal cells, varying the level of methylation in the dierent tissues. This methylation is not allele dependent, showing no imprinting eect. Surprisingly, increased speci®c hypermethylation of this area is found in p15
de®cient thymic lymphomas that do not have methylation in the CpG island of the promoter region. Using a luciferase reporter system, we show here that in vitro hypermethylation of the 3'-UTR produces decreased gene expression in NIH3T3 cells and this eect is mediated by at least two CpG sites in the p15
INK4b 3'-UTR. Thus, both types of hypermethylation, in the promoter or in the 3'-UTR, may act as alternative or cooperating mechanisms for p15
INK4b inactivation in T-cells.
Results
Characterization of a new methylation region in the 3'-UTR of p15
INK4b
The murine p15
INK4b gene, as the human counterpart, consists of two exons and one single intron between them. In RF/J mice, the exons 1 and 2 are¯anked by two XhoI sites in the 5' and 3' untranslated regions (UTR), giving rise to a 4.5 kb XhoI band (Figure 1 ). During the screening of CpG island methylation in thymus DNA, an extra band of about 6 kb was detected in XhoI6EcoRI digestions that could not be explained by methylation in the promoter region ( Figure 2a ). This band was present in all the samples, including normal and tumoral tissues. In order to characterize this DNA fragment, genomic DNA from a RF/J thymus was digested with XhoI and EcoRI and Figure 1 Physical map of the murine p15
INK4b gene from RF/J mice. The position of some of the primers used in this work is indicated (F1, Mp15E1F; F, Mp15F; 1R, Mp15-3'-1R; 3R, Mp15-3'-3R). The recognition sites and the expected size of the fragments produced after the digestion is also shown for the restriction enzymes more relevant to this work. In addition, the expected fragments after RT ± PCR ampli®cation and the position of the probes is indicated. Asterisks show restriction sites present in RF/J or DBA/2 DNA but absent in the C57BL/6J strain Tumor-associated hypermethylation of the p15 3'-UTR M Malumbres et al the fragments of about 6 kb were separated by gel electrophoresis and subcloned in pBLUESCRIPT KS + digested with EcoRI6SalI or SalI alone. This partial gene library was used to transform E. coli and the speci®c clones with the 6 kb fragment were detected by plate hybridization using the exon 1 of p15 INK4b as a probe. After selection and sequencing, these clones showed the presence of 6.0 kb XhoI ± EcoRI insert containing the genomic p15
INK4b gene and downstream sequences (Figure 1 ). There were no signi®cant nucleotide dierences with the previously known p15
INK4b sequence. Interestingly, the internal XhoI site in the 3'-UTR sequence was conserved in the cloned DNA fragment, indicating that it was protected from digestion in the genomic DNA. A similar cloning procedure was performed using genomic DNA from a C57BL/6J mammary gland. The cloned insert contains the same p15
INK4b gene with some nucleotide dierences. Some of them eliminate the XhoI/TaqI and NcoI sites as indicated in Figure 1 .
Thus, the XhoI site in the 3'-UTR is partially prevented from digestion in the normal thymus DNA from RF/J mice. Further analysis showed that the intensity of the 6 kb band was even higher in kidney DNA (Figure 2a) , indicating a stronger prevention of digestion in this site. To check whether this lack of digestion was due to CpG methylation or other factors like conformational dierences in the DNA, two dierent non methylation-sensitive restriction enzymes in the same region were used. Total kidney DNA was digested with NcoI to detect digestion in a NcoI site placed 13 bp downstream the XhoI site (Figure 1) , or with TaqI, whose recognition sequence (TCGA) is internal to the XhoI site (CTCGAG) and is not sensitive to methylation. Hybridization of these DNAs with a p15 (Figure 2b and c) indicating that CpG methylation is probably the cause of the lack of digestion at the XhoI site. Other methylationsensitive restriction enzyme, HpaII, was checked for methylation. There is one HpaII site in the coding sequence of exon 2, and other HpaII site 317 bp downstream, in the 3'-UTR of p15
INK4b (Figure 1 ). After digestion with HpaII6EcoRI and hybridization with the 3'-UTR probe, two bands of 317 bp and about 1.5 kb are expected. The presence of a third band of 1.8 kb indicates partial digestion of the HpaII site in the 3'-UTR and, in concordance with the results obtained with XhoI, the intensity of this extra band is stronger in kidney than in thymus. The control digestions with MspI (a restriction enzyme which recognizes the same sequence than HpaII, but is methylation-insensitive) showed complete digestion. No bands longer than 1.8 kb were detected in the HpaII digestions, indicating that the methylation is restricted to the HpaII site in the 3'-UTR and it does not aect the HpaII site in the coding region of exon 2. The p15
INK4b gene from other inbred strains as 129/J or DBA/2 was ampli®ed in a long-template PCR using primers Mp15E1F and Mp15-3'1R. These two mouse strains also have the XhoI site in the 3'-UTR, as detected by restriction mapping and sequencing, and similar pattern of methylation was found in the 3'-UTR of these strains (data not shown). Tissue-speci®c levels of 3'-UTR methylation
The pattern of p15
INK4b 3'-UTR methylation was then studied in dierent normal tissues. Genomic DNA was isolated from the brain, gut, heart, kidney, liver, lung, mammary gland, salivary gland, spleen, thymus and testis of DBA/2 mice. Since these mice only carry the 4.5 kb allele, the level of methylation was quanti®ed as the percentage of the 6.0 kb-band detected in XhoI6EcoRI digestions. The level of methylation in the p15
INK4b -UTR ranged from 20 ± 75% in these tissues (Figure 3a ). Whereas liver, spleen and thymus show low methylation at the XhoI site (about 20 ± 25%), the 6.0-kb band represents up to 60 ± 75% in brain, testis or gut. No signi®cant variation was found in thymus, kidney or lung tissues obtained from 1.5-month or 6-month mice (data not shown).
p15
INK4b expression and 3'-UTR methylation do not correlate in physiological conditions
Although undermethylation in the promoter regions usually correlate with gene expression, this is not a frequent ®nding in non-promoter regions as coding sequences, introns or 3'-UTR (Mullins et al., 1987; Borrello et al., 1992) . Since no methylation in the promoter CpG island of p15
INK4b is found in normal tissues, we analysed whether the 3'-UTR methylation was related to physiological tissue-speci®c gene expression. The abundance of p15
INK4b transcripts was evaluated by RT ± PCR using RNA from dierent DBA/2 tissues. As shown in Figure 3b , p15
INK4b
expression was detected in most of tissues, being high in testis and lung, and low in liver or brain. Most tissues with a low or intermediate level of methylation (thymus, spleen, lung or kidney) express p15
, however, a comparison of these results in Figure 3a and b indicates that there is no signi®cant correlation between 3'-UTR methylation and expression. For instance, the level of expression in thymus, kidney and gut are similar, although they are methylated to dierent extent (20%, 55%, 70%). In addition, low expression is found in liver (520% methylation) and brain (65% methylation).
We also checked whether 3'-UTR methylation is sensitive to cell cycle-dependent variation or changes with the alteration of p15
INK4b expression produced by external signals. Elimination of p15
INK4b expression during human lymphocyte mitogenesis was previously demonstrated and correlated to increased Rb phosphorylation (Lois et al., 1995) . Thus, p15
INK4b mRNA levels and DNA methylation were monitored in the activation of lymphocytes by mitogenic signals. Spleen lymphocytes from DBA/2 mice were activated with anti-CD3e, phorbol myristate acetate (PMA), ionomycin and concanavalin A. Cell samples were taken at dierent times (0, 20 and 50 h) and p15
INK4b DNA methylation and expression was analysed. No methylation changes were observed neither in the promoter nor in the 3'-UTR. However, p15 
Lack of imprinting in the murine p15
INK4b gene
Since methylation is a frequent phenomenon involved in parental imprinting, the restriction patterns in the p15
INK4b 3'-UTR could suggest an allele-speci®c methylation. To test this possibility, DNA and RNA were extracted from the inbred strains DBA/2 and C57BL/6J and from their F1 osprings: B6D2F1 (maternal C57BL/6J and paternal DBA/2) and D2B6F1 (maternal DBA/2 and paternal C57BL/6J). As described above, both strains, DBA/2 and C57BL/ 6J, dier in some nucleotides in their p15
INK4b sequence which produce a polymorphism in the XhoI site of the 3'-UTR. This site is present in DBA/2 but not in C57BL/6J, allowing the recognition of the parental origin of each allele. DNA from these strains was digested with XhoI6EcoRI, gel electrophoresed and transferred to nitrocellulose membranes. INK4b . Genomic DNA from eleven dierent DBA/2 tissues was digested with XhoI6EcoRI, gel electrophoresed, transferred to nitrocellulose membranes and hybridized with a p15
INK4b speci®c probe. The 6.0-kb band produced by partial digestion of the XhoI site in the 3'-UTR shows dierent relative intensities in the dierent tissues. The percentage of signal in the 6.0-kb band in two or three dierent hybridizations was plotted as an indication of the level of 3'-UTR methylation. (b) p15
INK4b expression in some mouse tissues. The histogram shows the relative levels of expression after normalization with the b-actin transcript and using the testis expression as relative value 1. p15
INK4b cDNA was detected after hybridization with a speci®c probe. b-actin expression was quanti®ed after ethidium bromide staining Tumor-associated hypermethylation of the p15 3'-UTR M Malumbres et al
In normal kidney, about 50% of the DNA is methylated (Figures 2 and 3 ) due either to partial methylation of both alleles or complete methylation of one allele and lack of methylation in the other. For instance, if the methylation was speci®c of the maternal allele, this would mean that the maternal allele is totally methylated and the paternal allele is not methylated at all. In that case, the analysis of the F1 ospring would show dierent levels of methylation depending on the parental origin of the allele. As detected after hybridization with the p15
INK4b 3'-UTR probe, the DBA/2 allele (4.5 kb band) from each of the B6D2F1 or D2B6F1 ospring is methylated to the same extent, with independence of its paternal (B6D2F1) or maternal origin (D2B6F1). About 50% of the 4.5-kb band is methylated in both types of F1 mice, indicating no parental eect on the methylation levels ( Figure 5a ). According to this, the level of gene expression of both alleles was found to be similar with independence of the parental origin (Figure 5b ). RT ± PCR was performed using primers speci®c for the exon 1 and the 3'-UTR region of the murine p15
INK4b gene, to avoid DNA contamination as template for the PCR (the strategy for this RT ± PCR and the size of the expected bands is shown in Figure 1 ). The parental origin of the allele was detected by digestion of the PCR products with XhoI, since the XhoI site in the 3'-UTR of DBA/2 is missing in the C57BL/6J cDNA (Figures 1 and 5b ).
De novo methylation of the p15 INK4b 3'-UTR in thymic lymphomas
To analyse if this newly discovered methylation sensitive area could be involved in the proliferation of neoplasias, as we had previously shown for the CpG island of the promoter, the pattern of methylation in the 3'-UTR of p15
INK4b was analysed in an extensive panel of thymic lymphomas induced by g-radiation or neutron-radiation or by treatment with MNU. Since there is a XhoI site in both the promoter and the 3'-UTR, the digestion with XhoI6EcoRI allows to detect methylation in both 5'-and 3'-regions, as graphically explained in Figure  6 . Some tumors induced in RF/J or 129/J mice show the pattern expected for the normal thymus, in which about 20% of the DNA is present as a 6-kb band due to partial methylation of the 3'-UTR. About 80% of shows a 6-kb band, since no internal XhoI is present in the 3'-UTR; DBA/2, which only carry the 4.5-kb band is 50% methylated giving rise to the 6-kb band. In F1 mice (D2B6F1 and B6D2F1), 75% of the signal is in the 6.0-kb band; 50% corresponds to the C57BL/6J allele (which is a`true' 6.0 kb DNA fragment) and 25% comes from the methylated 4.5-kb band (DBA/2 allele). About 25% of the DBA/2 allele remains unmethylated in all the F1 samples with independence of the parental origin. This membrane was hybridized with the 3'-UTR probe (Figure 1 ). (b) RT ± PCR products from C57BL/6J, DBA/2, B6D2F1 and D2B6F1 kidney RNA, showing equal levels of expression of the paternal and maternal alleles. cDNA from these tissues was ampli®ed by PCR using primers Mp15F and Mp15-3'-3R (Figure 1) . PCR products were digested with XhoI and the ampli®ed fragments were detected by hybridization with a 3'-UTR probe after gel electrophoresis and blotting onto a nitrocellulose membrane. The expected sizes of the RT ± PCR products after XhoI digestion is explained in Figure 1 Tumor-associated hypermethylation of the p15 3'-UTR M Malumbres et al the signal remains as the 4.5-kb band. As previously shown (Malumbres et al., 1997) , hypermethylation of the CpG island in some tumors is detected by the presence of a larger (10.5 kb) band, indicating lack of digestion in the XhoI site located in the promoter region (Figures 6 and 7) . Some other tumors show no CpG island methylation; however, the percentage of the 6-kb band is increased to more than 60% or even 100%, producing the disappearance of the 4.5-kb band and showing a strong de novo methylation in the 3'-UTR of p15
INK4b
. In a few cases, the increased methylation in the 3'-UTR is coincident with the methylation of the 5' CpG island; in these samples, the lack of digestion in both the 5' and 3' XhoI sites produces an additional 12-kb band, corresponding to the EcoRI fragment (Figures 6 and 7) . The frequency of methylation in the p15
INK4b promoter and 3'-UTR in the dierent type of induced tumors is shown in Figure 6 . In these data, only samples with a methylation in the CpG island higher than 30% are considered to be hypermethylated. However, the threshold was increased to 60% in the 3-UTR since about 20% of this area is methylated in the normal thymus. Hypermethylation of the CpG island in the promoter region is the most frequent event, although hypermethylation of the 3'-UTR with independence of the promoter region occurs in up to 19% of radiationinduced tumors and 31% of MNU-induced tumors. Hypermethylation in both 5' and 3' areas is relatively uncommon (Figure 6 ). p15
INK4b expression was analysed in murine thymic lymphomas by RT ± PCR using primers Mp15F and Mp15R, as explained in Materials and methods. Ampli®cation of b-actin cDNA was used as a control for RNA quality and concentration. The correlation between p15
INK4b gene inactivation and the methylation of the promoter CpG island has been shown previously (Herman et al., 1996; Malumbres et al., 1997) . In our samples, although most of the tumors (92%) with methylation in the promoter region have decreased p15
INK4b expression (Malumbres et al., 1997) , some lymphomas showed lack of p15
INK4b expression without hypermethylation of the CpG island. The analysis of the 3'-UTR methylation showed that most of these tumors have a strongly increased methylation in that region (Figure 7) . A representative sample of the tumors analysed is shown in Table 1 . These tumors were induced by g-radiation in B6RFF1 mice. Loss of heterozygosity (LOH) is a frequent event in these cells (Santos et al., 1996; Malumbres et al., 1997) . LOH in Table 1 was analysed by SSCP (Malumbres et al., 1997) and by using a new microsatellite adjacent to the p15
gene (Malumbres et al., 1998) . Seventeen tumors in Table 1 show lack of p15
INK4b expression. In one of them (R13B) the p15
INK4b gene inactivation can be attributed to a small deletion (data not shown). Ten out of the 16 remaining tumors (62.5%) have speci®c methylation of the CpG island in the promoter and four of them (25%) show speci®c hypermethylation of the 3'-UTR without promoter involvement. Interestingly, the only sample (6.3%) with strong hypermethylation in both regions (R6E) is the only tumor with decreased p15
INK4b expression without LOH. One additional sample (R6C) with p15
INK4b inactivation Figure 6 Patterns of methylation in the p15 INK4b promoter or 3'-UTR in dierent types of induced thymic lymphomas. Hypermethylation in the CpG island or in the 3'-UTR were considered to occur when the level of methylation in the XhoI or HpaII sites was higher than 30 or 60%, respectively
Tumor-associated hypermethylation of the p15 3'-UTR M Malumbres et al showed neither CpG island methylation nor strong hypermethylation in the 3'-UTR; however, methylation in the 3'-UTR was increased slightly. Taken together, these results indicate that both methylations in the 5' or 3' regions can be alternative and cooperating mechanisms for p15 INK4b gene inactivation.
Methylation of the 3'-UTR produces decreased gene expression in vitro
In order to analyse the eect of the 3'-UTR methylation on gene expression, two luciferase reporter plasmids were used in which the luc gene is driven by the thymidine kinase promoter without (ptkLUC+) or with the CMV enhancer (pCMVtkLUC+). Dierent fragments of the p15 INK4b 3'-UTR ( Figure 8a ) were ampli®ed by PCR as described in Materials and methods and CpG methylated in vitro using the SssI methylase. CpG methylation was demonstrated by the lack of HpaII digestion after treating with SssI. Methylated and nonmethylated fragments were inserted between the luc coding region and the SV40 late polyadenylation signal (pA). These recombinant constructs, without any bacterial passage, were used to transfect NIH3T3 cells. Luciferase activities were measured and normalized to b-galactosidase activities, used as an internal control. The amount of DNA and its identity were assesed by transformation of bacterial cells with an aliquot of the recombinant molecules. As shown in Figure 8B , methylation of the whole p15
INK4b 3'-UTR (fragment 1) produces decreased luciferase activity in both constructs containing the tk (P tk ) or the CMVtk (P CMV ) promoters. This decrease in the luciferase activity is specially high in the CMV plasmid, where only 30% of the activity remains after methylation of the 3'-UTR.
Since hypermethylation of the 3'-UTR in tumors ranges from 60 ± 100%, in vitro methylation of fragment 1 was performed at increasing times to obtain dierent levels of methylation. Thus, 4 min of incubation with SssI produced about 50% of methylated molecules whereas the methylation is almost complete in 15 min (90%) and totally complete in 60 min. When these partially methylated molecules were analysed for luciferase activity, a linear eect was observed between the level of methylation and light units produced (Figure 8c ).
Only ten CpG sites are present in the p15 INK4b 3'-UTR, a region with a very low percentage of CpG when compared with other fragments of the p15
INK4b
genomic DNA (Malumbres et al., 1997) . In order to further analyse the CpG sites responsible for this eect, several aditional fragments of the p15
INK4b 3'-UTR were ampli®ed. Thus, fragments 1, 2, 3, 4 and 5, which contain ten, eight, six, four or two CpG sites ( Figure  8a ) were analysed. In vitro methylation of all these fragments showed a similar eect on luciferase activity (Figure 8c ). The decrease of luciferase activity is similar using fragment 1, containing all the 10 CpG sites, and fragment 5, a 120-bp DNA fragment which contains the CpG sites present in the sequence recognized by the XhoI and HpaII restriction enzymes.
Discussion
The p53-and Rb-pathways are among the most frequently disrupted in cancer cells. In some type of tumors, as lung or esophageal carcinomas, almost 100% of cases have lesions in either p16
INK4a
, cyclin D1 or Rb, being the relative frequencies p16
INK4a 4 Cyclin D14Rb (Sherr, 1996) . For instance, deletion of p16
INK4a (and, in most of cases, p15
INK4b
) has been observed in 67% of non-small cell lung carcinomas and 68% glioblastomas (Hirama and Koeer, 1995) . In hematological malignancies, selective absence of p15
INK4b is found, virtually always due to hypermethylation of the CpG island in the promoter-exon 1 region INK4b in murine thymic lymphomas induced by g-irradiation (a), neutron-irradiation (b) or MNU treatment (c). (a) g-irradiation-induced tumor DNA was digested with HpaII6EcoRI and hybridized with the 3'-UTR probe. 1, normal thymus; 2 ± 9, tumor DNAs. Samples 2 and 3 and 5 ± 9 show increased methylation in the 3'-UTR. This methylation is almost 100% in tumors 2, 3, 5 and 6. RNA from these tumors was used for RT ± PCR analysis, showing decreased p15
INK4b expression in the tumors with 3'-UTR hypermethylation. (b) Thymic lymphomas induced by neutron-radiation. This panel shows the dierent patterns observed in the XhoI6EcoRI digestions (see Figure 6 ). 1, normal thymus DNA digested with EcoRI; 2, normal thymus DNA digested with XhoI x EcoRI; 3 ± 11, tumor DNA digested with XhoI6EcoRI. Samples 3, 4, 6, 7, 10 and 11 show hypermethylation in the 3'-UTR (6.0-kb and), reaching almost 100% in samples 7 and 9. Sample 4 shows partial hypermethylation in the CpG island and in the 3'-UTR, giving rise to the 6.0-, 10.5-and 12.0-kb bands. Sample 5 has strong hypermethylation in the promoter region (10.5-kb band) but not in the 3'-UTR. The presence of the 12.0-kb band in sample 9 indicates however hypermethylation in both 5' and 3' regions. (c) Tumors induced with MNU treatment. All the samples correspond to tumor DNA digested with XhoI6EcoRI. Samples 1, 2, 3, 4 and 10 show increased methylation of the 3'-UTR. No hypermethylation of the CpG island is found in these tumors Tumor-associated hypermethylation of the p15 3'-UTR M Malumbres et al rather than homozygous deletion (Herman et al., 1996 (Herman et al., , 1997 Batova et al., 1997) . Up to 88% of adult acute myelogenous leukemias or acute lymphocytic leukemias have speci®c methylation of the p15
INK4b CpG island, whereas there is neither methylation in p16
INK4a nor homozygous deletions in any of these INK4 genes. Similarly, hypermethylation of the murine p15
promoter CpG island occur in 88% of thymic lymphomas, whereas only 36% of these tumors show hypermethylation in p16
INK4a (Malumbres et al., 1997) . However, in the analysis of murine thymic lymphomas, we have detected some additional tumors in which the absence of p15
INK4b cannot be explained by promoter methylation. This fact led us to look for additional mechanisms of p15
INK4b inactivation. The presence of unexpected DNA bands which hybridized with a p15
-speci®c probe allowed us to detect methylation in the XhoI and HpaII sites of the p15
INK4b 3'-UTR in normal tissues (Figures 1 and 2 ). This area does not present the typical features for the CpG islands and it only contains a few CpG sites (Malumbres et al., 1997) . The detected methylation is restricted to the 3'-UTR and does not aect the HpaII site in the translated region of exon 2. The level of methylation varies depending on the tissue. Brain and gut show high methylation in the p15
INK4b 3'-UTR, whereas the lower levels of methylation are found in the hematopoietic tissues, thymus and spleen (Figure  3) , where it seems that p15
INK4b plays an important regulatory role in controlling growth (Lois et al., 1995; Herman et al., 1997; Malumbres et al., 1997) . Heritable, tissue-speci®c methylation patterns have been proposed to form the basis of a stable regulatory system (Riggs, 1975; Laird and Jaenisch, 1996) . Methyl group addition to DNA is proven to be necessary for normal development, apparently because it helps to shut down genes. Since both cell cycle inhibitors p16
INK4a and p15 INK4b are not expressed in embryogenesis (Zindy et al., 1997) , methylation of CpG sites other than the promoter CpG islands could play a role in the silencing of these genes in the embryonic development. Thus, most of tissue-speci®c genes are fully methylated in the germinal cells and become partially unmethylated in speci®c tissues (Razin and Cedar, 1991) . In our results, the 3'-UTR of p15
INK4b is highly methylated in testis and dierentially methylated in other tissues. No methylation is ever found in the CpG island of the promoter region in normal tissues.
It has been proposed that the methylation of the coding regions, introns or untranslated regions is relatively unimportant in comparison to methylation of the promoter regions, and there may be two levels of control operating independently. Methylation of the promoter region could be the primary switching mechanism; methylation of the other regions could provide only ®ne tuning (Riggs and Jones, 1983) . In the p15
INK4b gene, methylation of the 5' promoter region produces gene inactivation with independence of the R1B  R1C  R1D  R1E  R2B  R2C  R2D  R3A  R3B  R4A  R4B  R4C  R4D  R4E  R5B  R5C  R6B  R6C  R6E  R7A  R7B  R8A  R8D  R8E  R9A  R9B  R9C  R10A  R12A  R13A  R13B  R13C  R13E  R15B + 7 + 7 7 7 + 7 7 7
methylation status in the other areas, as can be observed in Tables 1 and 2 . Strong hypermethylation of the promoter always produces gene inactivation with independence of the 3'-UTR methylation status (correlation highly signi®cant, P50.001). Methylation of the 5' CpG island correlates also with LOH in the p15 INK4b locus (Table 2) . Although some correlation between expression and methylation in the non-promoter regions has been found (Battistizzi et al., 1985) , the lack of correlation is a frequent ®nding in tissue-speci®c genes (Mullins et al., 1987; Borrello et al., 1992) . In our results, methylation of the p15
INK4b 3'-UTR shows no correlation with tissue-speci®c expression or physiological inactivation of this gene in lymphocytes (Figures 3 and  4) . Thus, DNA methylation in the XhoI or HpaII sites of the 3'-UTR does not seem to have a major role in the control of p15 INK4b gene expression in several tissues and in physiological conditions. This fact does not mean that methylation in the 3'-UTR cannot play a role in p15
INK4b expression but probably there are other factors more important to determine the level of gene expression. However, we show a strong hypermethylation of the 3'-UTR associated with decreased expression in thymic lymphomas. This correlation is highly signi®cant (P50.001) in the samples which do not have methylation of the promoter area (Table 2 ). These dierent results may be due to the fact that methylation in the p15
INK4b 3'-UTR may have a signi®cant role on p15
INK4b transcription in a speci®c cell type when a threshold is reached in pathological conditions (neoplasia). For instance, high levels of methylation could be eective in inhibiting transcription in lymphocytes, since these normal cells have low methylation, but could have no eect in other cell types. As can be observed by comparing Figures 3 and  4 , 3'-UTR methylation is even lower (almost undetectable) in the isolated lymphocytes than in the whole thymus. Thus, a lower methylation threshold may be needed in thymus than in other tissues, as gut or testis, to be eective in down-regulating p15
INK4b expression.
Although promoter methylation of p15
INK4b is frequent in radiation-induced lymphomas, no hypermethylation of the CpG island has been found in MNU-induced tumors (Malumbres et al., 1997) . However, hypermethylation in the 3'-UTR is relatively frequent in these samples. These dierences are likely to be due to the dierent mutagenic mechanisms of MNU and ionizing radiation. It is worth noting that hypermethylation of the 3'-UTR cannot be explained as a simple extension of the hypermethylation in the CpG island located in the promoter region. There are mainly two reasons. First, hypermethylation of the 3'-UTR does not aect the HpaII site located in the coding region of exon 2, between the promoter and the Luciferase activities of the fragment 1 constructs carrying the non-methylated (white box) or methylated 3'-UTR (white box with rounded¯ags). P tk , thymidine kinase promoter; P CMV , thymidine kinase promoter and CMV enhancer; luc, luciferase gene; pA, SV40 late polyadenylation signal. The chart represents the average of three separate experiments. Light units corresponding to the nonmethylated forms were arbitrary set as 1. The actual values obtained with the constructs containing the CMV enhancer (P CMV ) were 50 ± 80 times higher than those obtained with the thymidine kinase promoter (P tk ). All values were normalized with respect to the b-galactosidase activity. (c) Methylation of fragments 1 ± 5 (as described in a) and luciferase activity. Fragment 1 was methylated for 0, 4, 15 or 60 min, whereas all the other fragments were methylated for 0 or 60 min. The level of methylation is shown by digestion with HpaII. About 50% or 90% of the molecules are methylated with 4 or 15 min. of incubation, whereas the reaction is always complete in 60 min. The relative luciferase activity of these constructs is shown below where all the non-methylated forms are arbitrary set to 1 INK4b expression
Tumor-associated hypermethylation of the p15 3'-UTR M Malumbres et al 3'-UTR. Second, although some samples show hypermethylation in the promoter and the 3'-UTR, strong hypermethylation of the 3'-UTR mostly occurs alternatively to promoter methylation (e.g. samples R1B, R2D, R4B, R4D and R13A in Table 1 or MNUinduced tumors). This is specially evident when considering samples with lack of p15 INK4b expression (Tables 1 and 2 ). Thus, the ®ne regulation putatively provided by the 3'-UTR could be overcome when strong methylation is present in this area. In other cases (R6E), this alteration could cooperate with the CpG island hypermethylation.
The partial or complete in vitro methylation of the p15
INK4b 3'-UTR produces, in fact, a decrease of gene expression as shown in the luciferase system (Figure 8) . Plasmids carrying the totally or partially CpGmethylated 3'-UTR show signi®cantly lower luciferase activity than the same plasmids without any methylation in the 3'-UTR. These data indicate that methylation in this area does interfere with some machinary involved in the regulation of transcription. Methyl groups may interfere, for instance, with the binding of individual proteins to DNA, and, in vivo, the variable binding of factors to DNA in dierent tissues correlates with the methylation pattern in those tissues (Razin and Cedar, 1991) . Transcription factors which bind to enhancer or promoter regions are included among the proteins whose DNA-binding ability is interfered by methylation (Watt and Molloy, 1988; Iguchi-Ariga and Schaner, 1989) . On the other hand, methylated DNA could be recognized by speci®c DNA binding proteins as MeCP2, which binds DNA with a single CpG methylation and have been demonstrated to inhibit transcription (Meehan et al., 1992; Nan et al., 1997) . Thus, the eect of methylation of the 3'-UTR (a region without CpG islands) on transcription should be dierent to that of methylation of promoter regions, where multiple CpG sites of the CpG islands are involved and the density of methylation in¯uences the level of transcription (Baylin et al., 1998) . In fact, as observed in Figure 8 , methylation of only two of the CpG sites (those recognized by the XhoI and HpaII restriction enzymes) is sucient to interfere with transcription.
Since all INK4 genes show tissue-speci®c expression (Zindy et al., 1997) , DNA methylation of nonpromoter regions could be present in the other members of the CDKI families. Recent studies are uncovering a high genetic complexity of the CDKIs and their mechanisms of regulation and inactivation. In addition to deletions, rearrangements, mutations and CpG island hypermethylation, these show additional complex features, including posttranscriptional (p21
) (Hatada and Mukai 1995; Pagano et al., 1995; Hengst and Reed, 1996; Li et al., 1996; Matsuoka et al., 1996; Shandu et al., 1997; Cost et al., 1997; ReynisdoÂ ttir and MassagueÂ 1997) . Regarding to untranslated regions, the transcriptional regulatory element proposed in this work for the p15
INK4b 3'-UTR is not unique in the CDKIs, since p21 WAF1/CIP1 has been shown to be not only posttranscriptionally regulated (Li et al., 1996) but also contains cis elements in its 3'-UTR involved in the regulation of transcription (Rishi et al., 1997) . In addition, the p21 WAF1/CIP1 3'-UTR contains three ARE motifs (5'-AUUUA-3'), involved in RNA instability (Savant-Bhonsale and Cleveland, 1992) , although its role is not clear in the p21 WAF1/CIP1 expression (Li et al., 1996) . At least two ARE motifs are present also in the murine p15
INK4b 3'-UTR, but their eect has not been studied yet.
Recently, a new alternative splicing form of p15
Mp15-3'-3R. The position of these probes is shown in Figure 1 . Sequencing of DNA was carried out with an automatic 373 DNA Sequencer (Applied Biosystems). For hybridizations, DNA was digested, separated on agarose gels, and transferred to nitrocellulose membranes (Schleicher & Schuell). Completion of enzyme digests was veri®ed by hybridization with other gene probes, as the murine p16 INK4a (exon 1), cyclin D1, or glyceraldehyde-3-phosphate dehydrogenase genes. Additional controls are described in the ®gure legends. DNA probes were labeled with [a-32 P]-dCTP (3000 Ci/mmol; Dupont-NEN) using a Random primed labeling kit (Boehringer Mannheim), according to the manufacturer's protocol. Hybridizations were visualized and quanti®ed by a PhosphorImager (Molecular Dynamics) or by exposing X-ray ®lms (Kodak), digital scanning and analysis with the NIH Image software.
The sequences of the p15 INK4b 3'-UTR and downstream regions were submitted to the GenBank database and were assigned accession numbers AF016457 (3'-UTR from DBA/2 mice) and AF015460 (exon 2, 3'-UTR and adjacent regions from C57BL/6J mice).
DNA ampli®cation, RNA isolation and RT ± PCR
Total cellular RNA from tissues or cultured cells was isolated using the guanidine thiocyanate method. Poly-(A) mRNA was isolated following the procedure described in the mRNA isolation kit (Quiagen), and DNA contamination was removed by digestion with DNaseI. cDNA was generated by reverse transcription of 5 mg of total RNA or 100 ng poly-(A) RNA using the MMLV reverse transcriptase (Life Technologies, Inc.) and a hexanucleotide mixture as a primer (Boehringer Mannheim). Standard PCR was performed in a Perkin Elmer Cetus DNA thermal cycler and consisted of 2 min at 958C, 20 ± 40 cycles of 30 s at 958C, 30 s at 588C and 1 min at 728C and a ®nal step of 5 min at 728C. Long-template PCR was performed using the Expand PCR kit (Boehringer Mannheim) and the manufacturer recommendations. Ampli®ed DNA was run in agarose gels and detected by ethidium bromide staining or by blotting and subsequent hybridization with probes speci®c for the murine p15
INK4b gene. The following primers were used in this work for PCR ampli®cation: Mp15E1F: 5'-TGC CAC AGA CCG GGG ACA AGG-3'; Mp15F: 5'-ATG TTG GGC GGC AGC AGT GA-3'; Mp15E1F3: 5'-TGA ACC GCT TCG GGA GGC GCC CAA T-3'; Mp15R: 5'-GTC AAT CTC CAG TGG CAG CG-3', Mp15-3'-1F: 5'-AGG TAT CTG CAC GCT GCC AGT GGA GAT-3'; Mp15-3'-1R: 5'-TAA CCA TGG AGA TCT CTC CAG GCT CCA-3'; Mp15-3'-3R: 5'-TTT GCA GGT GAA TCC CCA CAC ATG-3'; and Mp15-3'-4R: 5'-TAG AGG GCC CGG GAA CTT CAT AC-3'. When needed, PCR products were digested with XhoI by adding 10 units of the enzyme and the corresponding digestion buer over the PCR products and incubating at least 3 h at 378C. Quantitative RT ± PCR was performed using template dilutions or dierent number of ampli®cation cycles and comparing with the b-actin expression. b-actin cDNA was ampli®ed using primers b-actin-1F: 5'-GTG GGC CGC TCT AGG CAC CAA-3' and b-actin-1R: 5'-CTC TTT GAT GTC ACG CAC GAT TTC-3'.
Lymphocyte activation
Two 70-days old DBA/2 mouse were sacri®ced and spleen cells were cultured in RPMI 1640 medium for 2 h. Lymphocytes were then activated with 5 mg/ml anti-CD3e antibodies (Pharmigen), 100 ng/ml phorbol myristate acetate (PMA; Sigma), 0.5 mg/ml ionomycin (Sigma) and 10 mg/ml concanavalin A (Sigma). Samples were taken at 20 h and 50 h after activation for DNA and RNA analysis. Cells at time of activation (time 0) and non-activated cells at 50 h of culture were used as controls.
Luciferase assays
The p15
INK4b 3'-UTR was ampli®ed by PCR using primers Mp15UTR-F: 5'-CTA GGC CGG CCT CGA GCA AGG ACT TCT TTC TCC C-3' and Mp15UTR-R: 5'-GCG GGC CGG CCT CGA GTT TTT CTT TAA ATA CAC TG-3' (fragment 1, Figure 8a ); Mp15UTR-F and Mp15UTR2R: 5'-TAT GGC CGG CCG TCG ACA GGG GAA GGT ACT GAC-3' (fragment 2); Mp15UTR-F and Mp15UTR-3R: 5'-TAT GGC CGG CCT GAA AGG TAG AGG-3' (fragment 3); Mp15UTR-2F: 5'-ATT GGC CGG CCG CTG GAT CTG GTC-3' and Mp15UTR-2R (fragment 4); and Mp15UTR-2F and Mp15UTR-3R (fragment 5). All these primers contain an arti®cial FseI site. PCR product was digested with FseI (New England BioLabs) and puri®ed. Luciferase reporter plasmids ptkLUC+and pCMVtkLUC+(Altschmied and Duschl, 1997) were digested with FseI, treated with alkaline phosphatase (Boehringer Mannheim) and puri®ed. FseI-digested 3'-UTR was CpG methylated using the SssI methylase (New England BioLabs) and puri®ed. Methylated or nonmethylated 3'-UTR fragments were ligated to the luciferase plasmids for 16 h at 148C. Ligation products were separated in 1% agarose gel and the bands corresponding to the plasmids containing the insert were isolated. The identity of these bands was assesed by transformation of bacteria cells and restriction analysis of the plasmids. About 100 ng of puri®ed recombinant molecules and 1 mg of the bgalactosidase-expressing plasmid pCH110 (Pharmacia) were used to cotransfect NIH3T3 cells. Transient transfections were performed using the calcium phosphate method. Thirty-six hours after transfection, cells were collected and lysed using the buer provided in the Luciferase Assay System (Promega). Luciferase was assayed according the manufacturer recommendations. The same protein extracts were used then to measure the cheminoluminiscence produced by b-galactosidase using the Galacto-Light Plus system (Tropix).
